The transient increase in the frequencies of CD25+ cells among intrarenal Tcon during the short-term IL-2 treatment is in line with recent findings in peripheral blood of SLE patients treated with low doses of IL-2 and may indicate a certain lack of selectivity for Treg [18]. The gene discussed is IL2; the disease is systemic lupus erythematosus.